跳至主要内容
临床试验/NCT00544206
NCT00544206已完成2 期

Comparison of Enteral Products for Tube Fed Patients With Type 2 Diabetes

Abbott Nutrition1 个研究点 分布在 1 个国家目标入组 11 人开始时间: 2007年10月1日最近更新:
适应症
干预措施

试验速览

阶段
2 期
状态
已完成
入组人数
11
试验地点
1
主要终点
mean glucose level

研究概览

简要总结

To compare the glucose response in tube fed subjects with type 2 diabetes of a standard enteral product to that of a diabetes-specific enteral product

研究设计

研究类型
Interventional
分配方式
Non Randomized
干预模型
Crossover
主要目的
Treatment
盲法
None

入排标准

年龄范围
18 Years 至 75 Years(Adult, Older Adult)
性别
All
接受健康志愿者
否

入选标准

  • •signed and dated informed consent
  • •diagnosis of type 2 diabetes
  • •HbA1c between 7.0 and 9.0%
  • •18 - 75 years of age
  • •currently receiving a standard enteral product
  • •anticipated duration on tube feeding at least one month
  • •100% of patient's nutrient and energy needs are anticipated to be met by enteral nutrition support
  • •anticipated life expectancy is more than or equal to 6 months
  • •free of infections
  • •no change in medications within 2 weeks prior to screening that could profoundly affect blood glucose

排除标准

  • •composition of either product is inappropriate for the patient due to allergies or intolerance to any ingredient found in the study products
  • •composition of either product is inappropriate for the patient due to protein, fluid or electrolyte restrictions for concomitant conditions
  • •significant cardiovascular event less than or equal to 2 weeks prior to study entry
  • •major surgery less than or equal to 2 weeks prior to study entry
  • •pre-planned surgery during the study period
  • •active malignancy, including melanoma and excluding cutaneous malignancies
  • •severe dementia
  • •known allergies to medical grade adhesives and/or skin disinfectants
  • •taking octreotide
  • •chronic, contagious, infectious disease, such as active tuberculosis, Hepatitis B or C, or HIV
  • •participation in a concomitant trial

研究组 & 干预措施

#1

Experimental

Diabetes specific enteral feeding product

干预措施: Diabetes specific feeding product (Other)

#2

Active Comparator

Standard enteral feeding product

干预措施: standard enteral feeding product (Other)

结局指标

主要结局

mean glucose level

时间窗: 24 hours

次要结局

  • fasting capillary blood glucose level;percentage change from baseline in the dose and amount of antihyperglycemic medication(s), including insulin(24 hours)

研究者

申办方类型
Industry

研究点 (1)

Loading locations...

相似试验